The article discusses Figma's successful IPO, where shares surged from a $33 initial price to a closing price of $115.50, creating significant wealth for its investors following a three-year drought in tech IPOs. 

As for GE Healthcare (GEHC), its stock fell by -0.45% last night, likely due to broader market trends or specific factors impacting the healthcare sector, though the article does not provide explicit reasons for GEHC's decline.

The article discusses Figma's successful IPO, where shares surged from a $33 initial price to a clos

GE HealthCare (GEHC) reported better-than-expected second-quarter results and raised its full-year outlook, yet its stock fell by 7.82% due to a forecast for adjusted earnings per share that remains below earlier expectations and ongoing concerns about tariffs impacting profits.

GE HealthCare (GEHC) reported better-than-expected second-quarter results and raised its full-year o

The article compares GE Aerospace and Textron, highlighting that GE Aerospace has a higher dividend yield, greater revenue and earnings, and stronger institutional ownership, which may contribute to its stock's upward movement of 0.17%. The increase in the GE Healthcare stock could be attributed to its solid financial performance, robust dividends, and positive sentiment among institutional investors confident in its long-term growth.

The article compares GE Aerospace and Textron, highlighting that GE Aerospace has a higher dividend 

GE HealthCare Technologies Inc. (GEHC) experienced a 3.14% increase in its stock price, driven by positive analyst recommendations, a share repurchase plan indicating perceived undervaluation, and strong quarterly earnings that exceeded expectations.

GE HealthCare Technologies Inc

The article discusses a comparison between Northrop Grumman and GE Aerospace, with a focus on stock performance, institutional ownership, and dividend yield, noting that GE Healthcare (GEHC) stock rose 1.05% likely due to overall positive perceptions of its future growth potential compared to its peers and stable dividend payments.

The article discusses a comparison between Northrop Grumman and GE Aerospace, with a focus on stock 

GE Healthcare (GEHC) stock declined by 0.08% amid growing concerns among major corporations, including GEHC, about the risks associated with artificial intelligence (AI), leading to increased disclosures of these risks in financial filings.

GE Healthcare (GEHC) stock declined by 0

GE HealthCare Technologies Inc. (NASDAQ: GEHC) saw a decline of 1.79% in its stock value due to a series of recent price target cuts by analysts, which may have affected investor sentiment.

The article discusses controversy surrounding NFL Players Association executive director Lloyd Howell Jr., who continues to work part-time as a consultant for The Carlyle Group while leading the NFLPA, raising concerns about potential conflicts of interest. 

As for GE HealthCare (GEHC) stock's 1.31% increase, the article does not provide specific information on the reasons behind the stock's rise. Possible factors could include positive market trends, favorable business developments, or investor sentiment.

The article discusses controversy surrounding NFL Players Association executive director Lloyd Howel

GE HealthCare Technologies Inc. (NASDAQ: GEHC) saw a 0.79% increase in stock value, attributed to institutional investors adjusting their stakes, positive quarterly earnings exceeding expectations, and the initiation of a significant stock repurchase plan indicating management's confidence in the stock's value.

GE HealthCare Technologies Inc. (NASDAQ:GEHC) experienced a slight decrease of 0.07% in its stock price, attributed to recent modifications in holdings by institutional investors and fluctuating analyst ratings that may have impacted investor sentiment.

GE HealthCare Technologies (GEHC) stock rose 0.22% due to the company's recent reaffirmation of its commitment to shareholder value through a cash dividend declaration, an 8% increase in share price over the last month, securing FDA approvals for its imaging products, and positive broader market trends.

GE HealthCare Technologies (GEHC) stock rose 0

GE HealthCare (GEHC) saw a 2.54% increase in stock value, driven by significant investment from institutional investors boosting their stakes, positive quarterly earnings that surpassed estimates, and the announcement of a $1 billion stock buyback program, signaling management's confidence in the stock's value.

GE HealthCare (GEHC) saw a 2

GE HealthCare Technologies Inc. (GEHC) experienced a 2.54% increase in stock price, influenced by institutional investment activity, recent positive earnings results, approval of a significant stock buyback plan, and favorable analyst ratings despite some downward adjustments in price targets. 

The rise in GEHC stock is likely attributed to stronger-than-expected earnings, the announcement of a $1 billion share buyback, which signals confidence from management regarding the stock's value, and generally positive analyst sentiment, with most ratings indicating a buy.

GE HealthCare Technologies Inc. (NASDAQ:GEHC) experienced a 0.42% decline in its stock price, attributed in part to a slight reduction in shares held by Perigon Wealth Management LLC and several analysts lowering their price targets for the stock.

GE HealthCare Technologies Inc. (NASDAQ:GEHC) stock decreased by 0.42% due to various institutional investors adjusting their positions and a recent reduction in target prices from multiple analysts, indicating a shift in market sentiment.

GE HealthCare Technologies Inc. (NASDAQ:GEHC) experienced a 0.42% decline in stock price, attributed to analysts lowering price targets despite a consensus "Moderate Buy" rating, reflecting concerns on valuation and market conditions.

GE HealthCare Technologies Inc. (NASDAQ:GEHC) experienced a decline of 0.42% due to a combination of lowered price targets from several research analysts and broader market conditions despite recent positive earnings results and institutional investment activity.

GE HealthCare Technologies Inc. (NASDAQ:GEHC) experienced a decline of -0.64% in its stock value due to a possible market reaction influenced by recent analyst ratings adjusting price targets and overall sentiment, despite positive earnings reports and ongoing institutional investment.

GE HealthCare Technologies Inc. (NASDAQ:GEHC) saw its stock decline by 0.64% as several institutional investors adjusted their holdings, including International Assets Investment Management LLC which reduced its stake by 16.3%, indicating potential investor concerns or profit-taking that contributed to the stock's drop.

GE HealthCare Technologies Inc. (NASDAQ:GEHC) stock rose 2.9% following positive earnings performance that exceeded analysts' expectations and a recent stock repurchase authorization, indicating management's confidence in the company's value.

GE HealthCare Technologies Inc. (NASDAQ: GEHC) experienced a 1.07% increase in stock value, attributed to a recent positive quarterly earnings report that beat analyst expectations and various institutional investments, alongside a stock buyback plan suggesting the company’s leadership believes the stock is undervalued.

GE Healthcare Technologies Inc. (GEHC) experienced a 1.15% increase in its stock price, likely influenced by recent changes in institutional investor holdings, positive earnings results that exceeded analysts' expectations, and a stock buyback plan indicating confidence in the stock's value.

GE Healthcare Technologies Inc

GE HealthCare Technologies (GEHC) stock rose by 1.15% due to bullish sentiment driven by institutional investors increasing their holdings and positive earnings performance that exceeded expectations, along with the announcement of a significant share buyback plan signaling management's confidence in the company's valuation.

GE HealthCare Technologies (GEHC) stock rose by 1

GE HealthCare Technologies (NASDAQ:GEHC) saw a slight decline of 0.17% in its stock, attributed to modest reductions in holdings by key institutional investors and mixed analyst ratings that may have influenced investor confidence.

GE HealthCare Technologies (NASDAQ:GEHC) saw a slight decline of 0

GE Healthcare (GEHC) stock rose by 1.05% due to strong institutional ownership and positive analyst ratings, making it appear more favorable compared to competitors like Safran, alongside its solid revenue and attractive dividend yield.

GE Healthcare (GEHC) stock rose by 1

GE HealthCare Technologies Inc. (NASDAQ:GEHC) stock declined by 0.4% following increased scrutiny from analysts, including several downgrades and target price reductions from major brokerages, despite the company's positive quarterly earnings report and strategic share repurchase program.

GE Healthcare (GEHC) stock decreased by 0.4% due to analysts' concerns regarding GE Aerospace's potential downside of 9.87%, highlighting a stronger consensus rating for GE Aerospace compared to Chemring Group, leading to a perception of weaker investment performance for GEHC.

GE Healthcare (GEHC) stock decreased by 0

GE HealthCare Technologies Inc. (NASDAQ:GEHC) stock decreased by 0.7% recently, despite institutional investors increasing their stakes, likely due to a combination of recent price target adjustments by analysts and general market fluctuations.

GE Healthcare Technologies Inc. (GEHC) experienced a 0.7% decline in its stock price, attributed to analysts lowering their price targets and adjustments in fund positions despite positive quarterly earnings and dividend payouts.

GE HealthCare Technologies Inc. (NASDAQ:GEHC) saw a slight increase in its stock price, up 0.07%, following significant investments from institutional investors, including Procyon Advisors LLC raising their stake by 78.2%. The rise in GEHC stock can be attributed to increased institutional interest and positive analyst ratings despite some reductions in target prices.

GE HealthCare Technologies Inc. (NASDAQ:GEHC) saw a slight 0.1% increase in its stock price, attributed to significant investments from institutional investors such as Wellington Management Group and others, indicating growing confidence in the company's financial performance and stability.

GE HealthCare Technologies Inc. (GEHC) saw a 0.59% increase in stock price as it received a consensus "Moderate Buy" recommendation from brokers, driven by positive quarterly earnings that exceeded expectations and a recently approved $1 billion stock buyback program indicating the board's belief in the stock’s undervaluation.

GE Healthcare (GEHC) stock recently rose by 0.53%, likely due to strong institutional ownership and positive analyst recommendations compared to its peer GE Aerospace, indicating investor confidence in GEHC's long-term growth potential.

GE Healthcare (GEHC) stock recently rose by 0

GE HealthCare Technologies Inc. (NASDAQ:GEHC) saw a 0.2% increase in stock price due to growing institutional investment and positive quarterly earnings that exceeded analyst expectations. 

The stock rose because significant institutional investors raised their holdings, indicating confidence in the company's future prospects, and the recent announcement of a share repurchase plan, which suggests the management believes its shares are undervalued.

The article discusses GE Healthcare's stock performance, noting it was down 0.4%, but emphasizes GE Aerospace's strong turnaround and market growth post spin-off. GE Healthcare's decline could be attributed to broader market trends or investor sentiment shifting towards higher-growth opportunities like AI stocks, as suggested in the article.

The article discusses GE Healthcare's stock performance, noting it was down 0

GE HealthCare (GEHC) stock experienced a decline of 0.2% amidst a broader industry context where Citi analysts revised their MedTech coverage, highlighting how changes in U.S.–China tariff dynamics rendered previous forecasts less relevant and led to increased volatility in stock performance despite stable core fundamentals.

GE HealthCare (GEHC) stock experienced a decline of 0

GE Healthcare (GEHC) stock fell by 0.2% amid an overall weak market response to recent IPOs, particularly with Hinge Health's public debut highlighting challenges in the digital health sector, which could reflect broader investor caution.

GE Healthcare (GEHC) stock fell by 0

The article discusses the rise of hired-hand billionaires among American executives, highlighting their increasing wealth attributed to soaring stock prices and executive compensation, amidst a decline of the average pay of the highest-paid CEOs post-COVID. GE Healthcare (GEHC) stock saw a decrease of -0.04% likely due to broader market pressures or company-specific challenges, though the article does not specify the exact reasons for this decline.

The article discusses the rise of hired-hand billionaires among American executives, highlighting th

Vaso Corporation reported record first-quarter revenue of $19.5 million with an increase in gross profit, signaling financial stability, which may have positively influenced investor sentiment, leading to a 0.1% increase in GE Healthcare (GEHC) stock.

Vaso Corporation reported record first-quarter revenue of $19

GE Healthcare (GEHC) stock fell by 0.38% due to concerns about its inconsistency and heavy reliance on the Chinese market, leading analysts to advise against investing.

GE HealthCare Technologies Inc. (NASDAQ:GEHC) experienced a stock decline of 0.38%, attributed to short-term concerns about weak demand in China and general market volatility.

The article discusses a study on how specific oncogenic fusion genes associated with rhabdomyosarcoma bypass typical regulatory mechanisms and activate transcription pathways, and it notes that GE Healthcare (GEHC) stock rose by 2.44% due to increased investor confidence stemming from positive market trends and potential advancements in healthcare technologies, including promising research outcomes like those presented in the article.

The article discusses a study on how specific oncogenic fusion genes associated with rhabdomyosarcom

GE HealthCare Technologies (NASDAQ:GEHC) stock rose by 2.44%, despite analysts at Morgan Stanley reducing the price target from $86.00 to $78.00, likely due to a strong quarterly earnings report that beat estimates, an announced $1 billion share buyback plan, and generally positive market sentiment with most analysts rating the stock as a "buy" or "overweight."

GE HealthCare Technologies (NASDAQ:GEHC) stock rose by 2

Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) rose 2.44% as the company recently reported better-than-expected quarterly earnings, announced a share buyback program indicating confidence in its stock value, and received overall favorable ratings from analysts, reflecting a positive sentiment in the market.

Shares of GE HealthCare Technologies Inc

GE HealthCare (GEHC) stock fell by 1.64% due to the adverse effects of the U.S.-China tariff conflict on its earnings and sluggish hospital capital equipment spending in China.

GE HealthCare (GEHC) stock fell by 1

GE HealthCare Technologies’ stock increased by 4.23% mainly due to heightened trading volume, indicating strong investor interest within the healthcare sector amidst a broader market focus on stocks with substantial trading activity.

GE HealthCare Technologies’ stock increased by 4

GE HealthCare Technologies (NASDAQ: GEHC) saw a 4.23% increase in its stock price following the announcement of a $1.00 billion share buyback plan by its Board of Directors, indicating confidence in the company's valuation.

GE HealthCare Technologies (NASDAQ: GEHC) saw a 4

GE HealthCare Technologies Inc. (NASDAQ: GEHC) saw its stock price drop by 3.78% despite a stronger-than-expected earnings report, as the decline may be attributed to lower trading volume and varying analyst price targets following recent stock evaluations.

GE Healthcare (GEHC) stock fell by 3.78% following negative market sentiment stemming from reports detailing the challenges faced by Oracle Health, including customer losses that diminish the value of their Cerner acquisition and challenges posed by competitors like Epic, which undermine investor confidence in the healthcare technology sector.

GE Healthcare (GEHC) stock fell by 3

GE HealthCare's stock rose 3.29% following the company's strong Q1 2025 earnings report, which included an adjusted EPS of $1.01 that surpassed expectations and revenue of $4.78 billion that also beat forecasts, along with a record increase in orders by 10% year-over-year. The stock's increase can be attributed to better-than-expected financial performance, broad revenue growth, and a share buyback authorization demonstrating confidence in the company's long-term prospects.

GE HealthCare's stock rose 3

GE HealthCare (NASDAQ: GEHC) stock rose 3.29% following the company's report of first-quarter 2025 adjusted EPS at $1.01, exceeding expectations of 91 cents, along with higher sales of $4.78 billion, surpassing the consensus of $4.66 billion.

GE HealthCare (NASDAQ: GEHC) stock rose 3

GE HealthCare Technologies Inc. (NASDAQ:GEHC) experienced a slight increase of 0.03% in its stock value, driven by its recent launch of the FDA-approved Flyrcado imaging agent and advancements in AI technologies, despite some concerns regarding tariffs and trade tensions affecting profitability.

GE HealthCare Technologies (GEHC) stock increased by 0.03% as investors remain optimistic ahead of the upcoming Q1 2025 earnings report, where analysts expect strong performance, following a previous quarter where the company exceeded earnings estimates.

GE HealthCare Technologies (GEHC) stock increased by 0

The article compares GE Aerospace and Rheinmetall, highlighting GE Aerospace's stronger dividends, institutional ownership, revenue, and earnings, suggesting it is a more favorable investment, which likely contributed to GE Healthcare's slight stock increase of 0.03%. 

The increase in GE Healthcare's stock may be attributed to positive market sentiment surrounding GE Aerospace's favorable performance and analyst recommendations.

The article compares GE Aerospace and Rheinmetall, highlighting GE Aerospace's stronger dividends, i

GE HealthCare Technologies Inc. (NASDAQ: GEHC) experienced a slight increase of 0.03% in its stock, potentially due to its favorable position among D1 Capital's Daniel Sundheim's stock picks, indicating positive investor sentiment.

GE Healthcare (GEHC) stock increased by 0.03% amid a broader conversation on healthcare technology and innovation, although it has lost significant ground in innovation rankings according to a recent KLAS report. 

The stock's rise may be attributed to general market movements or positive sentiment related to healthcare technology developments, despite the company's challenges in maintaining competitiveness in innovation.

GE Healthcare (GEHC) stock increased by 0

GE HealthCare Technologies (GEHC) recently saw a 0.51% decline in its stock price, despite a 13% increase over the past week, likely due to broader market losses in the tech sector affecting sentiment.

GE HealthCare Technologies (GEHC) recently saw a 0

GE HealthCare Technologies Inc. (NASDAQ:GEHC) saw its stock rise by 2.0% due to significant options trading activity, with a notable increase in call options purchased, along with favorable actions from hedge funds and analysts expressing positive outlooks on the stock. 

The rise in GEHC stock can be attributed to unusual options trading, substantial investments from hedge funds, and positive analyst ratings and target price increases.

GE HealthCare Technologies Inc. (NASDAQ:GEHC) experienced a 2.57% decline in stock value, despite receiving a generally favorable "Moderate Buy" rating from analysts, due to a combination of recent earnings results that slightly missed revenue expectations and general market conditions impacting healthcare stocks.

GE Healthcare (GEHC) stock fell by 4.16% amid escalating US-China trade tensions and the announcement of high tariffs by President Donald Trump on Chinese imports, which raises concerns about the broader economic implications for multinational companies operating in the affected regions.

GE Healthcare (GEHC) stock fell by 4

GE Healthcare (GEHC) stock dropped by 3.67% due to escalating trade conflicts between the U.S. and China, which have created uncertainty in global markets, impacting companies like GEHC that are involved in international trade.

GE Healthcare (GEHC) stock dropped by 3

GE Healthcare (GEHC) stock was up 0.79% due to positive sentiment following a meeting with Chinese officials, where they encouraged American businesses, including GEHC, to take action regarding tariffs, suggesting openness to foreign investment.

GE Healthcare (GEHC) stock was up 0

The article reports that GE Healthcare (GEHC) stock was up 0.79% despite a broader market decline due to fears surrounding the U.S.-China trade war and its economic implications. The increase in GEHC stock may be attributed to investor confidence in its resilience amidst challenging market conditions, or possibly because it was less affected than other companies with heavy exposure to China.

The article reports that GE Healthcare (GEHC) stock was up 0

The article discusses the ongoing international trade tensions and tariff disputes initiated by the U.S. administration, highlighting responses from various countries, including China and the European Union, while also noting that GE Healthcare was part of discussions related to these tariffs. GE Healthcare's stock likely rose by 0.79% due to positive investor sentiment following negotiations between U.S. companies and the Chinese government, where assurances for continued foreign investment were made.

The article discusses the ongoing international trade tensions and tariff disputes initiated by the 

Despite a tumultuous market influenced by heightened U.S.-China trade tensions, GE Healthcare's stock rose by 0.79% likely due to investors seeking opportunities in a volatile market and the company's resilience compared to other stocks impacted more severely.

Despite a tumultuous market influenced by heightened U

GE Healthcare's stock rose by 0.79% amid ongoing global trade tensions, particularly as the company was included in discussions with Chinese officials about addressing tariffs, suggesting a potential pathway for reducing trade barriers and fostering investment.

GE Healthcare's stock rose by 0

GE Healthcare (GEHC) stock fell 16% due to the heightened fears of a global recession following China's retaliation to U.S. tariffs, affecting companies that rely significantly on trade with China.

GE Healthcare (GEHC) stock fell 16% due to the heightened fears of a global recession following Chin

The article reports that GE Healthcare (GEHC) stock fell by 15.96%, attributed to a potential decline in investor confidence due to anticipated market trends or company performance issues, though specific reasons were not detailed in the article.

The article reports that GE Healthcare (GEHC) stock fell by 15

GE Healthcare (GEHC) stock fell by 16% due to broader market concerns stemming from escalating global trade tensions, specifically China's retaliation against U.S. tariffs, which heightened fears of a potential recession affecting international economic stability.

GE Healthcare (GEHC) stock fell by 16% due to broader market concerns stemming from escalating globa

GE Healthcare (GEHC) stock fell 15.96% due to heightened fears from escalating U.S.-China trade tensions, which significantly impacted investor sentiment and led to broad market losses, particularly for companies with substantial exposure to the Chinese market.

GE Healthcare (GEHC) stock fell 15

GE HealthCare (GEHC) stock fell by 16.0% in response to escalating trade tensions as China retaliated against U.S. tariffs, significantly impacting the company's sales, with 12% of its revenue coming from China and a substantial portion of its products manufactured there.

GEHC

Latest News & Analysis